Target Opthalmics French medical device manufacturer FCI S.A.S. specializes in oculoplastie and retina, with a focus on addressing tear and dry eye conditions as well as eyelid, orbital, and retinal pathologies—indicating potential opportunities to align ophthalmology distributors and clinics with their innovative devices.

R&D Stronghold Over four decades of R&D investment and collaboration with expert surgeons suggest a mature product pipeline and ongoing development needs; sales outreach can emphasize customization, surgeon-led design, and expansion of instrument sets or implantables that integrate with existing practices.

Made in Besançon Majority of devices developed and manufactured at a single French site with integrated R&D, production, logistics, and quality; potential selling points include supply chain reliability, short lead times, and potential for on-site demonstrations or localized training.

US Market Presence Active international footprint through FCI Ophtalmics in the United States and Canada for nearly 20 years; opportunities exist to expand cross-border sales, regional partnerships, and reseller agreements to accelerate market access in North America.

Early-Stage Revenue Current revenue under one million with a lean employee base; sales discussions can propose scalable product bundles, entry-level devices, and education programs to grow adoption while aligning with budget-conscious healthcare providers.